AbbVie

IRS: 320375147
ABBV
AbbVie

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Founded
2012 (9 years)
Investor RelationsSEC
Revenue
46 billion (2020)

Want to see more? Sign up!